Nicotine dependence, other tobacco product, with withdrawal
ICD-10 F17.293 is a billable code used to indicate a diagnosis of nicotine dependence, other tobacco product, with withdrawal.
F17.293 refers to nicotine dependence associated with the use of tobacco products other than cigarettes, such as cigars, pipes, or smokeless tobacco, accompanied by withdrawal symptoms. Nicotine dependence is characterized by a strong craving for nicotine, tolerance to its effects, and withdrawal symptoms when nicotine use is reduced or stopped. Withdrawal symptoms may include irritability, anxiety, difficulty concentrating, increased appetite, and cravings for tobacco. The diagnosis is made based on clinical assessment and the presence of these symptoms following cessation or reduction of tobacco use. Treatment often involves behavioral therapies, counseling, and pharmacotherapy, including nicotine replacement therapies (NRT) and non-nicotine medications like varenicline or bupropion. Understanding the nuances of nicotine dependence and withdrawal is crucial for effective treatment and management, as well as for accurate coding and billing.
Comprehensive assessment of substance use history, withdrawal symptoms, and treatment response.
Patients presenting with withdrawal symptoms after cessation of tobacco use.
Ensure accurate documentation of all tobacco products used and the severity of dependence.
Detailed mental health assessment, including co-occurring disorders.
Patients with nicotine dependence and comorbid mental health conditions.
Documenting the impact of nicotine withdrawal on mental health status.
Used during a visit for counseling a patient with nicotine dependence.
Document the duration of counseling and specific cessation strategies discussed.
Addiction specialists may provide more intensive counseling.
Withdrawal symptoms can include irritability, anxiety, difficulty concentrating, increased appetite, and strong cravings for tobacco.
